O'Toole David D 4

What Happened
David D. O'Toole, Chief Financial Officer of AVITA Medical, reported an open-market purchase of 3,000 shares on 2026-02-19 at $4.15 per share, for a total transaction value of $12,450. This transaction is a purchase, which some investors view as a positive signal since an insider is adding to their stake.

Key Details

• Transaction date and price: 2026-02-19 — 3,000 shares at $4.15 each (total $12,450). Transaction type: P (purchase, open market or private purchase).
• Filing date: Form 4 filed 2026-02-23 (filed within the standard two-business-day window).
• Shares owned after transaction: Not specified in the provided filing excerpt. Footnote F1 notes that reported ownership includes unvested RSUs.
• No 10b5-1 plan, cashless exercise, gift, or tax-withholding notes were indicated in the provided details.

Context
This was a straightforward open-market purchase rather than an option exercise or award. The dollar size ($12.45k) is modest relative to many insider transactions; purchases can be informative but do not on their own prove future company performance. The filing appears timely under insider reporting rules.